Literature DB >> 8269391

Human immunodeficiency virus type 1 infection of the brain.

W J Atwood1, J R Berger, R Kaderman, C S Tornatore, E O Major.   

Abstract

Direct infection of the central nervous system by human immunodeficiency virus type 1 (HIV-1), the causative agent of AIDS, was not appreciated in the early years of the AIDS epidemic. Neurological complications associated with AIDS were largely attributed to opportunistic infections that arose as a result of the immunocompromised state of the patient and to depression. In 1985, several groups succeeded in isolating HIV-1 directly from brain tissue. Also that year, the viral genome was completely sequenced, and HIV-1 was found to belong to a neurotropic subfamily of retrovirus known as the Lentivirinae. These findings clearly indicated that direct HIV-1 infection of the central nervous system played a role in the development of AIDS-related neurological disease. This review summarizes the clinical manifestations of HIV-1 infection of the central nervous system and the related neuropathology, the tropism of HIV-1 for specific cell types both within and outside of the nervous system, the possible mechanisms by which HIV-1 damages the nervous system, and the current strategies for diagnosis and treatment of HIV-1-associated neuropathology.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8269391      PMCID: PMC358293          DOI: 10.1128/CMR.6.4.339

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  367 in total

1.  HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency.

Authors:  M H Malim; B R Cullen
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

2.  Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.

Authors:  J V Garcia; A D Miller
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

3.  The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

Authors:  G J Clements; M J Price-Jones; P E Stephens; C Sutton; T F Schulz; P R Clapham; J A McKeating; M O McClure; S Thomson; M Marsh
Journal:  AIDS Res Hum Retroviruses       Date:  1991-01       Impact factor: 2.205

4.  Effects of prednisone on human immunodeficiency virus infection.

Authors:  F T Saulsbury; K A Bringelsen; D E Normansell
Journal:  South Med J       Date:  1991-04       Impact factor: 0.954

5.  The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: a morphological and immunohistochemical study.

Authors:  A Ciardi; E Sinclair; F Scaravilli; N J Harcourt-Webster; S Lucas
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes.

Authors:  F Bachelerie; J Alcami; F Arenzana-Seisdedos; J L Virelizier
Journal:  Nature       Date:  1991-04-25       Impact factor: 49.962

7.  Susceptibility of primary human glial fibrillary acidic protein-positive brain cells to human immunodeficiency virus infection in vitro: anti-HIV activity of memantine.

Authors:  P G Rytik; V F Eremin; Z B Kvacheva; N N Poleschuk; S A Popov; H C Schröder; M Bachmann; B E Weiler; W E Müller
Journal:  AIDS Res Hum Retroviruses       Date:  1991-01       Impact factor: 2.205

8.  Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection.

Authors:  S Peudenier; C Hery; L Montagnier; M Tardieu
Journal:  Ann Neurol       Date:  1991-02       Impact factor: 10.422

9.  Mild brain atrophy in early HIV infection: the lack of association with cognitive deficits and HIV-specific intrathecal immune response.

Authors:  I Elovaara; E Poutiainen; R Raininko; L Valanne; A Virta; S L Valle; J Lähdevirta; M Iivanainen
Journal:  J Neurol Sci       Date:  1990-11       Impact factor: 3.181

10.  New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases.

Authors:  D M Holtzman; D A Kaku; Y T So
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

View more
  23 in total

1.  CD4/CXCR4-independent infection of human astrocytes by a T-tropic strain of HIV-1.

Authors:  B Schweighardt; J T Shieh; W J Atwood
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

Review 2.  Virus receptors in the human central nervous system.

Authors:  B Schweighardt; W J Atwood
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

3.  Loss of neuronal integrity during progressive HIV-1 infection of humanized mice.

Authors:  Prasanta K Dash; Santhi Gorantla; Howard E Gendelman; Jaclyn Knibbe; George P Casale; Edward Makarov; Adrian A Epstein; Harris A Gelbard; Michael D Boska; Larisa Y Poluektova
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

Review 4.  Vertical human immunodeficiency virus-1 infection: involvement of the central nervous system and treatment.

Authors:  C Exhenry; D Nadal
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

Review 5.  Neuropsychiatric aspects of HIV infection.

Authors:  I P Everall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

Review 6.  Immune modulation by estrogens: role in CNS HIV-1 infection.

Authors:  Melinda E Wilson; Filomena O Dimayuga; Janelle L Reed; Thomas E Curry; Carol F Anderson; Avindra Nath; Annadora J Bruce-Keller
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

7.  Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines.

Authors:  G V Raj; K Khalili
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

Review 8.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 9.  Benzodiazepines, glia, and HIV-1 neuropathogenesis.

Authors:  J R Lokensgard; C C Chao; G Gekker; S Hu; P K Peterson
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

10.  Possible involvement of both endoplasmic reticulum- and mitochondria-dependent pathways in MoMuLV-ts1-induced apoptosis in astrocytes.

Authors:  Na Liu; Xianghong Kuang; Hun-Taek Kim; George Stoica; Wenan Qiang; Virginia Lee Scofield; Paul K Y Wong
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.